FDAnews Drug Daily Bulletin

SEATTLE GENETICS AND LAUREATE PHARMA ANNOUNCE MANUFACTURING AGREEMENT

April 26, 2006
A A

Seattle Genetics, Inc. and Laureate Pharma, Inc. announced today that they have entered into an agreement for manufacturing of Seattle Genetics' SGN-33 and SGN-70 humanized monoclonal antibody product candidates. Under the terms of the agreement, Laureate Pharma will perform scale-up and cGMP manufacturing of clinical trial materials for both programs.
Business Wire